These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37778042)

  • 1. Cilostazol for the management of moyamoya disease: a systematic review of the early evidence, efficacy, safety, and future directions.
    Abedi A; Sizdahkhani S; Choi W; Nguyen VN; Rennert RC; Russin JJ
    Neurosurg Focus; 2023 Oct; 55(4):E9. PubMed ID: 37778042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Effects between Clopidogrel and Cilostazol on Cerebral Perfusion in Nonsurgical Adult Patients with Symptomatically Ischemic Moyamoya Disease: Subanalysis of a Prospective Cohort.
    Chiba T; Setta K; Shimada Y; Yoshida J; Fujimoto K; Tsutsui S; Yoshida K; Kobayashi M; Kubo Y; Fujiwara S; Terasaki K; Ogasawara K
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3373-3379. PubMed ID: 30174225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study.
    Seo WK; Kim JY; Choi EH; Kim YS; Chung JW; Saver JL; Bang OY; Kim GM
    J Am Heart Assoc; 2021 Feb; 10(5):e017701. PubMed ID: 33615836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilostazol for treatment of cerebral infarction.
    Noma K; Higashi Y
    Expert Opin Pharmacother; 2018 Oct; 19(15):1719-1726. PubMed ID: 30212227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilostazol may improve cognition better than clopidogrel in non-surgical adult patients with ischemic moyamoya disease: subanalysis of a prospective cohort.
    Ando S; Tsutsui S; Miyoshi K; Sato S; Yanagihara W; Setta K; Chiba T; Fujiwara S; Kobayashi M; Yoshida K; Kubo Y; Ogasawara K
    Neurol Res; 2019 May; 41(5):480-487. PubMed ID: 30774013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failures in Revascularization for Pediatric Moyamoya Disease and Syndrome: A Scoping Review.
    Shlobin NA; Frankel HG; Lam S
    World Neurosurg; 2021 May; 149():204-214.e1. PubMed ID: 33618047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet Treatment in Moyamoya Disease: A Systematic Review.
    Kijpaisalratana N; Ariyaprakai C; Sriamornrattanakul K; Wongsuriyanan S; Akharathammachote N; Susantitaphong P; Suwanwela NC
    Cerebrovasc Dis Extra; 2024; 14(1):76-85. PubMed ID: 38697036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult Moyamoya Disease and Moyamoya Syndrome: What Is New?
    Uchiyama S; Fujimura M
    Cerebrovasc Dis Extra; 2024; 14(1):86-94. PubMed ID: 39043157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Revascularization for Pediatric Patients with Sickle Cell Disease and Moyamoya Disease in the Prevention of Ischemic Strokes: A Single-Center Case Series and a Systematic Review.
    Aguilar-Salinas P; Hayward K; Santos R; Agarwal V; Sauvageau E; Hanel RA; Aldana PR
    World Neurosurg; 2019 Mar; 123():435-442.e8. PubMed ID: 30496928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
    Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
    J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Cilostazol: A Critical Review of Its Antithrombotic and Cardiovascular Actions and Its Clinical Applications.
    Manolis AA; Manolis TA; Melita H; Mikhailidis DP; Manolis AS
    J Clin Pharmacol; 2022 Mar; 62(3):320-358. PubMed ID: 34671983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk profile in extracranial/intracranial bypass surgery--the role of antiplatelet agents, disease pathology, and surgical technique in 168 direct revascularization procedures.
    Schubert GA; Biermann P; Weiss C; Seiz M; Vajkoczy P; Schmiedek P; Thomé C
    World Neurosurg; 2014 Nov; 82(5):672-7. PubMed ID: 23838364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilostazol for Secondary Stroke Prevention: History, Evidence, Limitations, and Possibilities.
    de Havenon A; Sheth KN; Madsen TE; Johnston KC; Turan TN; Toyoda K; Elm JJ; Wardlaw JM; Johnston SC; Williams OA; Shoamanesh A; Lansberg MG
    Stroke; 2021 Oct; 52(10):e635-e645. PubMed ID: 34517768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, prevalence, and treatment of Moyamoya disease in Japan: A population-based descriptive study.
    Liu H; Fukasawa T; Anno T; Takeuchi M; Shimazaki S; Yang T; Kawakami K
    J Stroke Cerebrovasc Dis; 2024 Aug; 33(8):107770. PubMed ID: 38768667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
    Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
    J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy may improve the prognosis of patients with moyamoya disease: a 12-year retrospective study.
    Luo Y; Cao Z; Ye H; Wu S; Sun X
    J Neurol; 2023 Aug; 270(8):3876-3884. PubMed ID: 37106259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous thrombolysis and endovascular thrombectomy for acute ischaemic stroke in patients with Moyamoya disease - a systematic review and meta-summary of case reports.
    Koh MY; Toh KZ; Ho JS; Yeo LL; Ho AF; Sia CH; Tan BY
    J Thromb Thrombolysis; 2022 Aug; 54(2):339-349. PubMed ID: 35699873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
    Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
    Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.